Zhongyianke Biotech

About:

Zhongyianke Biotech is a biotechnology firm.

Website: http://www.gazobiotech.com/

Top Investors: EFung Capital, Med-Fine Capital, China Securities, Huaige Capital, Shenzhen Qianhai Beizeng Asset Management

Description:

Zhongyianke has launched a flu vaccine and is conducting clinical trials on four other human vaccines: a tetravalent influenza vaccine, a tetravalent meningococcal vaccine, a rabies vaccine, and a rubella vaccine. The company holds 14 China patents. In addition to its operations in Tianjin, the company has an R&D center in Beijing and a production facility in Liaoning Province.